TScan Therapeutics, Inc.

TScan Therapeutics, Inc. financial statements

TScan Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 10.32M10-K
Net income−USD 129.77M10-K
Cash and equivalentsUSD 152.41M10-Q
Total debtUSD 32.53M10-K

TScan Therapeutics, Inc. financials on 6ix · TScan Therapeutics, Inc. on 6ix